Legal & General Group’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,646
Closed -$100K 3780
2021
Q1
$100K Sell
2,646
-2,846
-52% -$108K ﹤0.01% 2622
2020
Q4
$93K Buy
5,492
+281
+5% +$4.76K ﹤0.01% 2607
2020
Q3
$24K Sell
5,211
-1,156
-18% -$5.32K ﹤0.01% 2930
2020
Q2
$38K Sell
6,367
-634
-9% -$3.78K ﹤0.01% 2810
2020
Q1
$15K Sell
7,001
-1,130
-14% -$2.42K ﹤0.01% 3042
2019
Q4
$37K Sell
8,131
-2,713
-25% -$12.3K ﹤0.01% 2950
2019
Q3
$42K Buy
10,844
+2,846
+36% +$11K ﹤0.01% 2814
2019
Q2
$48K Sell
7,998
-17,750
-69% -$107K ﹤0.01% 2795
2019
Q1
$345K Buy
25,748
+13,510
+110% +$181K ﹤0.01% 2222
2018
Q4
$114K Hold
12,238
﹤0.01% 2427
2018
Q3
$171K Buy
12,238
+562
+5% +$7.85K ﹤0.01% 2374
2018
Q2
$185K Sell
11,676
-1,092
-9% -$17.3K ﹤0.01% 2315
2018
Q1
$219K Sell
12,768
-790
-6% -$13.6K ﹤0.01% 2281
2017
Q4
$298K Buy
13,558
+3,277
+32% +$72K ﹤0.01% 2213
2017
Q3
$416K Buy
10,281
+826
+9% +$33.4K ﹤0.01% 2129
2017
Q2
$288K Buy
9,455
+287
+3% +$8.74K ﹤0.01% 2184
2017
Q1
$331K Buy
9,168
+2,583
+39% +$93.3K ﹤0.01% 2126
2016
Q4
$332K Buy
6,585
+2,833
+76% +$143K ﹤0.01% 2087
2016
Q3
$194K Sell
3,752
-325
-8% -$16.8K ﹤0.01% 2034
2016
Q2
$169K Buy
4,077
+208
+5% +$8.62K ﹤0.01% 1841
2016
Q1
$160K Buy
3,869
+527
+16% +$21.8K ﹤0.01% 1809
2015
Q4
$137K Hold
3,342
﹤0.01% 1909
2015
Q3
$51K Hold
3,342
﹤0.01% 2440
2015
Q2
$81K Hold
3,342
﹤0.01% 2272
2015
Q1
$79K Hold
3,342
﹤0.01% 2201
2014
Q4
$90K Hold
3,342
﹤0.01% 2066
2014
Q3
$40K Buy
+3,342
New +$40K ﹤0.01% 2498